Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
dTub
Скачать

ICH Q11 Q&A - A Supporting Document for the Selection and Justification of Starting Materials

Автор: U.S. Food and Drug Administration

Загружено: 2021-03-11

Просмотров: 4626

Описание:

FDA discusses key concepts and clarification for starting materials selection based on ICH Q11 Q&A.
Presenter:
Anita Tiwari, Division of Lifecycle API

Learn more at: https://www.fda.gov/drugs/news-events...
-------------------- 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  
 
Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accoun...
SBIA 2021 Playlist -    • 2021 CDER Small Business and Industry Assi...  
SBIA LinkedIn:   / cder-small-business-and-industry-assistance  
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter -   / fda_drug_info  
Email - [email protected]  
Phone - (301) 796-6707 I (866) 405-5367

ICH Q11 Q&A - A Supporting Document for the Selection and Justification of Starting Materials

Поделиться в:

Доступные форматы для скачивания:

Скачать видео mp4

  • Информация по загрузке:

Скачать аудио mp3

Похожие видео

Drug Substance Facilities – Hidden and Critical Intermediate

Drug Substance Facilities – Hidden and Critical Intermediate

Medical Device Quality Management System Regulation Risk Management

Medical Device Quality Management System Regulation Risk Management

Process Validation and ICH Q7

Process Validation and ICH Q7

Investigational New Drug (IND) Submission: Content/Format and First 30 Days (5of14) REdI 2018

Investigational New Drug (IND) Submission: Content/Format and First 30 Days (5of14) REdI 2018

OTC Monograph Reform: OTC Sunscreen Drugs

OTC Monograph Reform: OTC Sunscreen Drugs

FDA Direct: Catching Up on Agency Reforms

FDA Direct: Catching Up on Agency Reforms

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018

Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

Evaluation of Metal Impurities in Drug Substances

Evaluation of Metal Impurities in Drug Substances

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Expert Panel on Testosterone Replacement Therapy for Men

Medical Device Quality Management System Regulation Design and Development

Medical Device Quality Management System Regulation Design and Development

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel

ICH Q12 Guidance and Emerging Technology Program (11of16) Generic Drugs Forum 2020

ICH Q12 Guidance and Emerging Technology Program (11of16) Generic Drugs Forum 2020

Drug Master File (DMF) Submissions on New FDA Form 3938

Drug Master File (DMF) Submissions on New FDA Form 3938

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...

© 2025 dtub. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]